{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:05:58Z","timestamp":1790633158229,"version":"4.1.0"},"reference-count":28,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jmsacl.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T13:03:57Z","timestamp":1708088637000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Endogenous monoclonal immunoglobulins analyzed using the EXENT\u00ae solution and LC-MS"],"prefix":"10.21627","volume":"32","author":[{"given":"David","family":"Barnidge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Troske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"5","key":"10.1016\/j.jmsacl.2024.02.002_b0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/ac00077a003","article-title":"Characterization of humanized anti-TAC, an antibody directed against the interleukin 2 receptor, using electrospray ionization mass spectrometry by direct infusion, LC\/MS, and MS\/MS","volume":"66","author":"Lewis","year":"1994","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.02.002_b0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mas.20129","article-title":"Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals","volume":"26","author":"Srebalus Barnes","year":"2007","journal-title":"Mass Spectrom. Rev."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.02.002_b0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/ac3032355","article-title":"Characterization of therapeutic antibodies and related products","volume":"85","author":"Beck","year":"2013","journal-title":"Anal. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jmsacl.2024.02.002_b0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.molimm.2011.09.002","article-title":"Rapid LC-MS screening for IgG Fc modifications and allelic variants in blood","volume":"49","author":"Goetze","year":"2011","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.02.002_b0025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/pmic.200800715","article-title":"IgG glycosylation analysis","volume":"9","author":"Huhn","year":"2009","journal-title":"Proteomics"},{"issue":"9\u201310","key":"10.1016\/j.jmsacl.2024.02.002_b0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/prca.201300077","article-title":"Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients","volume":"8","author":"Remily-Wood","year":"2014","journal-title":"Proteomics Clin. Appl."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.02.002_b0035","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/pr5000544","article-title":"Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC- MS\/MS","volume":"13","author":"Barnidge","year":"2014","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.jmsacl.2024.02.002_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1373\/clinchem.2015.242651","article-title":"Clonotypic light chain peptides identified for monitoring minimal residual disease in multiple myeloma without bone marrow aspiration","volume":"62","author":"Bergen","year":"2016","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.02.002_b0045","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/pr400985k","article-title":"Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy","volume":"13","author":"Barnidge","year":"2014","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.02.002_b0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjh.13003","article-title":"Detecting monoclonal light chains in urine: microLC-ESI-Q- TOF mass spectrometry compared to immunofixation electrophoresis","volume":"167","author":"Botz","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.jmsacl.2024.02.002_b0055","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/pr5005967","article-title":"Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry","volume":"13","author":"Barnidge","year":"2014","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.jmsacl.2024.02.002_b0060","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1021\/acs.jproteome.5b00711","article-title":"Subset of kappa and lambda germline sequences result in light chains with a higher molecular mass phenotype","volume":"14","author":"Barnidge","year":"2015","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.jmsacl.2024.02.002_b0065","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1021\/acs.analchem.6b00544","article-title":"Using mass spectrometry to quantify rituximab and perform individualized immunoglobulin phenotyping in ANCA-associated vasculitis","volume":"88","author":"Mills","year":"2016","journal-title":"Anal. Chem."},{"issue":"288","key":"10.1016\/j.jmsacl.2024.02.002_b0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2015.09.011","article-title":"Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry","volume":"15","author":"Barnidge","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"21","key":"10.1016\/j.jmsacl.2024.02.002_b0075","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/rcm.7314","article-title":"Using matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine","volume":"29","author":"Barnidge","year":"2015","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"10","key":"10.1016\/j.jmsacl.2024.02.002_b0080","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1373\/clinchem.2015.253740","article-title":"Comprehensive assessment of M-proteins using nanobody enrichment coupled to MALDI- TOF mass spectrometry","volume":"62","author":"Mills","year":"2016","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.jmsacl.2024.02.002_b0085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1373\/clinchem.2015.253781","article-title":"Screening method for M-proteins in serum using nanobody enrichment coupled to MALDI-TOF mass spectrometry","volume":"62","author":"Kohlhagen","year":"2016","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.jmsacl.2024.02.002_b0090","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajh.24772","article-title":"The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic","volume":"92","author":"Milani","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.jmsacl.2024.02.002_b0095","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3026(22)00069-2","article-title":"Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study","volume":"9","author":"El-Khoury","year":"2022","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.jmsacl.2024.02.002_b0100","doi-asserted-by":"crossref","unstructured":"Matthias. Mann, Chin Kai. Meng, John B. Fenn, Interpreting mass spectra of multiply charged ions. Anal. 21. Liu YD, Goetze AM, Bass RB, Flynn GC. N-terminal glutamate to pyroglutamate conversion in vivo for human IgG2 antibodies, J. Biol. Chem. 286(13) (2011) 11211\u201311217.","DOI":"10.1074\/jbc.M110.185041"},{"issue":"10","key":"10.1016\/j.jmsacl.2024.02.002_b0105","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1016\/j.xphs.2019.05.023","article-title":"Cyclization of N-terminal glutamic acid to pyro-glutamic acid impacts monoclonal antibody charge heterogeneity despite its appearance as a neutral transformation","volume":"108","author":"Liu","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jmsacl.2024.02.002_b0110","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1021\/acs.chemrev.1c00696","article-title":"Approaches to heterogeneity in native mass spectrometry","volume":"122","author":"Rolland","year":"2022","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.jmsacl.2024.02.002_b0115","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1021\/acs.analchem.9b05272","article-title":"A universal score for deconvolution of intact protein and native electrospray mass spectra","volume":"92","author":"Marty","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2024.02.002_b0120","unstructured":"C. Wijnands, S. Noori, N.W.C.J.V. Donk, M.M. VanDuijn, J.F.M. Jacobs, Advances in minimal residual disease monitoring in multiple myeloma, Crit. Rev. Clin. Lab. Sci. 26 (2023) 1\u201317. Chem. 61(15) (1989) 1702\u20131708."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.02.002_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-021-00418-2","article-title":"Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation","volume":"11","author":"Derman","year":"2021","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.02.002_b0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1515\/cclm-2020-1072","article-title":"Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top- down mass spectrometry, and middle-down de novo sequencing","volume":"59","author":"Deighan","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.02.002_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/jms.4909","article-title":"A multiparameter optimization in middle- down analysis of monoclonal antibodies by LC-MS\/MS","volume":"58","author":"Dhenin","year":"2023","journal-title":"J. Mass Spectrom."},{"issue":"24","key":"10.1016\/j.jmsacl.2024.02.002_b0140","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1021\/acs.analchem.3c01426","article-title":"Added value of internal fragments for top-down mass spectrometry of intact monoclonal antibodies and antibody-drug conjugates","volume":"95","author":"Wei","year":"2023","journal-title":"Anal. Chem."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:45Z","timestamp":1767770565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X24000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"alternative-id":["S2667145X24000154"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.02.002","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous monoclonal immunoglobulins analyzed using the EXENT\u00ae solution and LC-MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL).","name":"copyright","label":"Copyright"}]}}